Sharo, C.; Zhang, J.; Zhai, T.; Bao, J.; Garcia-Epelboim, A.; Mamourian, E.; Shen, L.; Huang, Z.
Repurposing FDA-Approved Drugs Against Potential Drug Targets Involved in Brain Inflammation Contributing to Alzheimer’s Disease. Targets 2024, 2, 446-469.
https://doi.org/10.3390/targets2040025
AMA Style
Sharo C, Zhang J, Zhai T, Bao J, Garcia-Epelboim A, Mamourian E, Shen L, Huang Z.
Repurposing FDA-Approved Drugs Against Potential Drug Targets Involved in Brain Inflammation Contributing to Alzheimer’s Disease. Targets. 2024; 2(4):446-469.
https://doi.org/10.3390/targets2040025
Chicago/Turabian Style
Sharo, Catherine, Jiayu Zhang, Tianhua Zhai, Jingxuan Bao, Andrés Garcia-Epelboim, Elizabeth Mamourian, Li Shen, and Zuyi Huang.
2024. "Repurposing FDA-Approved Drugs Against Potential Drug Targets Involved in Brain Inflammation Contributing to Alzheimer’s Disease" Targets 2, no. 4: 446-469.
https://doi.org/10.3390/targets2040025
APA Style
Sharo, C., Zhang, J., Zhai, T., Bao, J., Garcia-Epelboim, A., Mamourian, E., Shen, L., & Huang, Z.
(2024). Repurposing FDA-Approved Drugs Against Potential Drug Targets Involved in Brain Inflammation Contributing to Alzheimer’s Disease. Targets, 2(4), 446-469.
https://doi.org/10.3390/targets2040025
